Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients
<p>Abstract</p> <p>Background</p> <p>H1N1 is responsible for the first influenza pandemic in 41 years. In the fall of 2009, an H1N1 vaccine became available in Canada with the hopes of reducing the overall effect of the pandemic. The purpose of this study was to assess...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Online Access: | http://www.aacijournal.com/content/7/1/3 |